Clinical Trial Update: Evaluating the Impact of Early Versus Delayed 5 Alpha Reductase Inhibitor Treatment on the Risk of Emergent Surgery in Men With Benign Prostatic Hyperplasia

View source ↗

Summary

This completed trial evaluated early versus delayed 5-alpha reductase inhibitor therapy in men with benign prostatic hyperplasia. Results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• DUTASTERIDE (Dutasteride)
• FINASTERIDE (FINASTERIDE)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Prostatic Hyperplasia | Status: COMPLETED | Results posted: 2012-02-29